151 related articles for article (PubMed ID: 9735242)
21. Dual cell cycle-specific mechanisms mediate the antimitogenic effects of nitric oxide in vascular smooth muscle cells.
Sarkar R; Gordon D; Stanley JC; Webb RC
J Hypertens; 1997 Mar; 15(3):275-83. PubMed ID: 9468455
[TBL] [Abstract][Full Text] [Related]
22. Nitric oxide stimulates guanylate cyclase and regulates sodium transport in rabbit proximal tubule.
Roczniak A; Burns KD
Am J Physiol; 1996 Jan; 270(1 Pt 2):F106-15. PubMed ID: 8769828
[TBL] [Abstract][Full Text] [Related]
23. Functional localization of soluble guanylate cyclase in turtle retina: modulation of cGMP by nitric oxide donors.
Blute TA; Velasco P; Eldred WD
Vis Neurosci; 1998; 15(3):485-98. PubMed ID: 9685201
[TBL] [Abstract][Full Text] [Related]
24. Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms.
Takata M; Filippov G; Liu H; Ichinose F; Janssens S; Bloch DB; Bloch KD
Am J Physiol Lung Cell Mol Physiol; 2001 Feb; 280(2):L272-8. PubMed ID: 11159006
[TBL] [Abstract][Full Text] [Related]
25. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells.
Beasley D; Schwartz JH; Brenner BM
J Clin Invest; 1991 Feb; 87(2):602-8. PubMed ID: 1671393
[TBL] [Abstract][Full Text] [Related]
26. NADPH and heme redox modulate pulmonary artery relaxation and guanylate cyclase activation by NO.
Gupte SA; Rupawalla T; Phillibert D; Wolin MS
Am J Physiol; 1999 Dec; 277(6):L1124-32. PubMed ID: 10600882
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism.
Marsden PA; Ballermann BJ
J Exp Med; 1990 Dec; 172(6):1843-52. PubMed ID: 1979590
[TBL] [Abstract][Full Text] [Related]
28. Regulation of NO-elicited pulmonary artery relaxation and guanylate cyclase activation by NADH oxidase and SOD.
Gupte SA; Rupawalla T; Mohazzab-H KM; Wolin MS
Am J Physiol; 1999 May; 276(5):H1535-42. PubMed ID: 10330236
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period.
Bloch KD; Filippov G; Sanchez LS; Nakane M; de la Monte SM
Am J Physiol; 1997 Mar; 272(3 Pt 1):L400-6. PubMed ID: 9124595
[TBL] [Abstract][Full Text] [Related]
30. Secretion of cyclic GMP by cultured epithelial and fibroblast cell lines in response to nitric oxide.
Patel MJ; Wypij DM; Rose DA; Rimele TJ; Wiseman JS
J Pharmacol Exp Ther; 1995 Apr; 273(1):16-25. PubMed ID: 7536242
[TBL] [Abstract][Full Text] [Related]
31. Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents.
Papapetropoulos A; Marczin N; Mora G; Milici A; Murad F; Catravas JD
Hypertension; 1995 Oct; 26(4):696-704. PubMed ID: 7558233
[TBL] [Abstract][Full Text] [Related]
32. [Effect of glucose on soluble guanylate cyclase in cultured rat mesangial cells].
Kajiwara N; Kikkawa R; Haneda M; Shigeta Y
Nihon Jinzo Gakkai Shi; 1993 Feb; 35(2):105-13. PubMed ID: 8100285
[TBL] [Abstract][Full Text] [Related]
33. Age-related changes in the NMDA receptor/nitric oxide/cGMP pathway in the hippocampus and cerebellum of freely moving rats subjected to transcerebral microdialysis.
Vallebuona F; Raiteri M
Eur J Neurosci; 1995 Apr; 7(4):694-701. PubMed ID: 7542528
[TBL] [Abstract][Full Text] [Related]
34. Chronic exposure to aluminium impairs the glutamate-nitric oxide-cyclic GMP pathway in the rat in vivo.
Hermenegildo C; Sáez R; Minoia C; Manzo L; Felipo V
Neurochem Int; 1999 Mar; 34(3):245-53. PubMed ID: 10355491
[TBL] [Abstract][Full Text] [Related]
35. Cell cycle effects of nitric oxide on vascular smooth muscle cells.
Sarkar R; Gordon D; Stanley JC; Webb RC
Am J Physiol; 1997 Apr; 272(4 Pt 2):H1810-8. PubMed ID: 9139967
[TBL] [Abstract][Full Text] [Related]
36. Regulation of heme oxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide.
Hartsfield CL; Alam J; Cook JL; Choi AM
Am J Physiol; 1997 Nov; 273(5):L980-8. PubMed ID: 9374724
[TBL] [Abstract][Full Text] [Related]
37. Comparative effects of exogenous nitrovasodilators on cGMP levels in different canine blood vessels.
Bina S; Hart JL; Muldoon SM
Life Sci; 1995; 56(2):PL33-8. PubMed ID: 7823754
[TBL] [Abstract][Full Text] [Related]
38. [Study on the effect of endothelin and nitric oxide on DNA synthesis of pulmonary artery smooth muscle cells and modulation of hypoxia].
Feng X; Cai Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Jun; 17(3):172-7. PubMed ID: 8706150
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a novel monoclonal antibody that senses nitric oxide-dependent activation of soluble guanylate cyclase.
Tsuyama S; Yamazaki E; Tomita T; Ihara H; Takenaka S; Kato K; Kozaki S
FEBS Lett; 1999 Jul; 455(3):291-4. PubMed ID: 10437791
[TBL] [Abstract][Full Text] [Related]
40. Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide.
Severina IS
Biochemistry (Mosc); 1998 Jul; 63(7):794-801. PubMed ID: 9721331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
